Cytokinetics(DE:KK3A)
€51.56-0.90 (-1.72%)
DE:KK3A
Cytokinetics earnings date
€51.56
At close:-0.90 (-1.72%)
Cytokinetics (KK3A) Q2 2022 Earnings Report
4 Followers
DE:KK3A Q2 2022 EPS Results
- Actual EPS
- -EUR 0.21
- Consensus EPS
- -EUR 0.92
- Beat/Miss
- Beat by +EUR 0.72
- One Year Ago EPS
- -EUR 0.77
DE:KK3A Q2 2022 Revenue Results
- Actual Revenue
- EUR 79.66M
- Expected Revenue
- EUR 3.34M
- Beat/Miss
- Beat by +EUR 76.32M
- YoY Revenue Growth
- +3029.37%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- After Close
- Conference Call
- Thursday, August 4, 2022
DE:KK3A Upcoming Earnings
Cytokinetics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:KK3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -1.26- | -1.34 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -1.28-1.23 | -2.28 | 46.27% (+1.06) | |
| Aug 06, 2026 | 2026 (Q2) | -1.46-1.34 | -1 | -33.93% (-0.34) | |
| May 05, 2026 | 2026 (Q1) | -1.48-1.50 | -1.22 | -22.79% (-0.28) | |
| Feb 24, 2026 | 2025 (Q4) | -1.40-1.34 | -1.13 | -19.05% (-0.21) | |
| Nov 05, 2025 | 2025 (Q3) | -1.41-2.28 | -1.22 | -87.50% (-1.07) | |
| Aug 07, 2025 | 2025 (Q2) | -1.28-1.00 | -1.17 | 14.50% (+0.17) | |
| May 06, 2025 | 2025 (Q1) | -1.23-1.22 | -1.19 | -2.26% (-0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -1.07-1.13 | -1.24 | 8.70% (+0.11) | |
| Nov 06, 2024 | 2024 (Q3) | -1.11-1.22 | -1.21 | -0.74% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
